Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(13%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_3
1
13%
Ph phase_1
1
13%
Ph early_phase_1
1
13%
Ph not_applicable
5
63%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (12.5%)
Phase 11 (12.5%)
Phase 31 (12.5%)
N/A5 (62.5%)

Trials by Status

completed450%
recruiting113%
terminated113%
unknown225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8